RU2005102681A - STRAIN AEROCOCCUS VIRIDANS N167K, WHICH MANIFESTES ANTI-MICROBIAL ACTIVITY AND A MEDICINAL PRODUCT BASED ON ITS "VIABAK" - Google Patents

STRAIN AEROCOCCUS VIRIDANS N167K, WHICH MANIFESTES ANTI-MICROBIAL ACTIVITY AND A MEDICINAL PRODUCT BASED ON ITS "VIABAK" Download PDF

Info

Publication number
RU2005102681A
RU2005102681A RU2005102681/13A RU2005102681A RU2005102681A RU 2005102681 A RU2005102681 A RU 2005102681A RU 2005102681/13 A RU2005102681/13 A RU 2005102681/13A RU 2005102681 A RU2005102681 A RU 2005102681A RU 2005102681 A RU2005102681 A RU 2005102681A
Authority
RU
Russia
Prior art keywords
strain
viabak
manifestes
product based
medicinal product
Prior art date
Application number
RU2005102681/13A
Other languages
Russian (ru)
Other versions
RU2292390C2 (en
Original Assignee
Общество с ограниченной ответственностью "ВИРИДАНС" (UA)
Общество с ограниченной ответственностью "ВИРИДАНС"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Общество с ограниченной ответственностью "ВИРИДАНС" (UA), Общество с ограниченной ответственностью "ВИРИДАНС" filed Critical Общество с ограниченной ответственностью "ВИРИДАНС" (UA)
Publication of RU2005102681A publication Critical patent/RU2005102681A/en
Application granted granted Critical
Publication of RU2292390C2 publication Critical patent/RU2292390C2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Claims (2)

1. Штамм A. viridans 167K (р.н. ИМВ В-7069), который проявляет противомикробную активность.1. The strain A. viridans 167K (b. IMV B-7069), which exhibits antimicrobial activity. 2. Лечебное средство Виабак (Viabac), отличающееся тем, что содержит терапевтически эффективное количество лиофилизированных вегетативных клеток A. viridans 167K (р.н. ИМВ В-7069) и фармацевтично приемлемый носитель.2. The drug Viabac (Viabac), characterized in that it contains a therapeutically effective amount of lyophilized vegetative cells A. viridans 167K (R.N. IMV B-7069) and a pharmaceutically acceptable carrier.
RU2005102681/13A 2004-09-10 2005-01-14 Aerococcus viridans STRAIN N 167 K HAVING ANTI-MICROBIAL ACTIVITY AND PHARMACEUTICAL AGENT BASED ON THE SAME RU2292390C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
UA20040907406 2004-09-10
UA20040907406A UA72065C2 (en) 2004-09-10 2004-09-10 Strain aerococcus viridans 167k imb b-7069 with antibacterial activity and "viabac" preparation comprising this strain

Publications (2)

Publication Number Publication Date
RU2005102681A true RU2005102681A (en) 2006-07-10
RU2292390C2 RU2292390C2 (en) 2007-01-27

Family

ID=34618247

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2005102681/13A RU2292390C2 (en) 2004-09-10 2005-01-14 Aerococcus viridans STRAIN N 167 K HAVING ANTI-MICROBIAL ACTIVITY AND PHARMACEUTICAL AGENT BASED ON THE SAME

Country Status (3)

Country Link
RU (1) RU2292390C2 (en)
UA (1) UA72065C2 (en)
WO (1) WO2006028428A1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1057424A (en) * 1963-09-19 1967-02-01 Rhone Poulenc Sa New antibiotic and process for its manufacture
JPS6022915B2 (en) * 1978-07-20 1985-06-04 東洋醸造株式会社 Method for producing L-α-glycerophosphate oxidase
SU1406156A1 (en) * 1986-07-16 1988-06-30 Днепропетровский медицинский институт Strain of aerococcus viridans bacteria for producing clones with oxidase and reductase activity
CH680045A5 (en) * 1990-02-16 1992-06-15 Om Lab Sa

Also Published As

Publication number Publication date
WO2006028428A1 (en) 2006-03-16
UA72065C2 (en) 2005-01-17
RU2292390C2 (en) 2007-01-27

Similar Documents

Publication Publication Date Title
USD959687S1 (en) Cosmetic skin care device
JP2007523135A5 (en)
IL184288A0 (en) 18-methyl-19-nor-17-pregn-4-en-21,17-carbolactones and pharmaceutical preparations comprising the same
WO2009062746A3 (en) Topical drugs for use in antifungal therapy
BR0207025B1 (en) isoxazoline derivative and herbicide containing the same as the active ingredient.
DK1763339T3 (en) Oral antimicrobial pharmaceutical preparations
WO2006138048A3 (en) Formulations comprising fluphenazine or derivatives thereof
MXPA03003029A (en) Active ingredient combinations with insecticidal, fungicidal and acaricidal properties.
EP1731609A4 (en) Rad51 EXPRESSION INHIBITOR, DRUG CONTAINING THE INHIBITOR AS THE ACTIVE INGREDIENT AND UTILIZATION THEREOF
ITMI20022292A1 (en) 9A-AZALIDS WITH ANTI-INFLAMMATORY ACTIVITY.
DE602005027231D1 (en) CYLGLYCEROLS AND THERAPEUTIC USES THEREOF
IL187575A (en) Benzofuranyl derivatives ,pharmaceutical formulations comprising the same and use thereof in the preparation of medicaments for the treatment of 5-ht6-receptor related disorders
ITMI20021725A1 (en) PHARMACEUTICAL COMPOSITIONS WITH ANTIBIOTIC ACTIVITY.
WO2006083927A3 (en) Antimicrobial agent
EP2006287A4 (en) Compound with antimalarial activity and antimalarial drug containing the same as active ingredient
CL2003001692A1 (en) USE OF N- (3-METOXI-5-METHYLPIRAZIN-2-IL) -2- (4- [1,3,4-OXADIAZOL-2-IL] PHENYL) PIRIDINA-3-SULFONAMIDE IN THE PREPARATION OF A MEDICINAL PRODUCT THE CANCER TREATMENT IN A HOT BLOOD ANIMAL.
ATE465741T1 (en) 9A-CARBAMOYL-Y-AMINOPROPYL AND 9A-THIOCARBAMOYL-Y-AMINOPROPYL AZALIDES WITH ANTIMALARIA ACTIVITY
RU2005102681A (en) STRAIN AEROCOCCUS VIRIDANS N167K, WHICH MANIFESTES ANTI-MICROBIAL ACTIVITY AND A MEDICINAL PRODUCT BASED ON ITS "VIABAK"
JP2006527741A5 (en)
WO2007071721A3 (en) Ginger extract for inhibiting human drug transporters
HRP20040691A2 (en) 2'-halo-3',5'-dialkoxyphen-1'-yl-imino-2-imidazolidine and the use thereof as a drug
IL182125A0 (en) Optically active 4,4-di-substituted oxazolidine derivatives and processes for the preparation thereof
JP2005531640A5 (en)
EE200200215A (en) Use of 2-amino-3,4-dihydroquinazolines for the preparation of a medicament for the treatment or prevention of diseases caused by ischemic conditions
ITFE20020007A1 (en) COMPOUNDS WITH ANTIFLAVIVIRIDAE ACTIVITIES, THEIR PREPARATION AND PHARMACEUTICAL PREPARATIONS THAT CONTAIN THEM.

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20200115